+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ardelyx Inc - logo

Ardelyx Inc - Company & Market Research Reports

Following a company allows Research and Markets to customize your experience and provide personalized recommendations.
2019 Hyperphosphatemia In Chronic Kidney Disease Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 Hyperphosphatemia In Chronic Kidney Disease Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • 73 Pages
From
Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Drug Development Pipeline Review, 2018

  • Report
  • 159 Pages
From
Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H1 2018 - Product Thumbnail Image

Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H1 2018

  • Drug Pipelines
  • 50 Pages
From
Diarrhea and Constipation Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Diarrhea and Constipation Drug Development Pipeline Review, 2018

  • Report
  • 93 Pages
From
Constipation Therapeutics - Pipeline Analysis 2017, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments - Product Thumbnail Image

Constipation Therapeutics - Pipeline Analysis 2017, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments

  • Report
  • 101 Pages
From
2019 Hyperkalemia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 Hyperkalemia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • 71 Pages
From
2019 Hyperphosphatemia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 Hyperphosphatemia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • 221 Pages
From
2019 Irritable Bowel Syndrome Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 Irritable Bowel Syndrome Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • 274 Pages
From
2019 Constipation Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 Constipation Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • 353 Pages
From
Global Short Bowel Syndrome Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025 - Product Thumbnail Image

Global Short Bowel Syndrome Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • Report
From
Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 355 Pages
From
Constipation Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Constipation Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 358 Pages
From
2018 Constipation Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 Constipation Drug Development- Pipeline Analysis Report

  • Report
  • 67 Pages
From
2018 Diarrhea Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 Diarrhea Drug Development- Pipeline Analysis Report

  • Report
  • 70 Pages
From
2018 Irritable Bowel Syndrome Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 Irritable Bowel Syndrome Drug Development- Pipeline Analysis Report

  • Report
  • 70 Pages
From
Non-Alcoholic Steatohepatitis (NASH) - Pipeline Insight, 2019 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) - Pipeline Insight, 2019

  • Drug Pipelines
  • 90 Pages
From
2018 Critical Limb Ischemia (CLI) Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 Critical Limb Ischemia (CLI) Drug Development- Pipeline Analysis Report

  • Report
  • 76 Pages
From
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H1 2019 - Product Thumbnail Image

Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H1 2019

  • Drug Pipelines
  • 296 Pages
From
Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H1 2019 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H1 2019

  • Drug Pipelines
  • 787 Pages
From
Diarrhea - Pipeline Insight, 2019 - Product Thumbnail Image

Diarrhea - Pipeline Insight, 2019

  • Drug Pipelines
  • 90 Pages
From
Loading Indicator
adroll